Erratum to “Is inhaled prophylactic heparin useful for prevention and management of pneumonia in ventilated ICU patients? The IPHIVAP investigators of the Australian and New Zealand Intensive Care Society Clinical Trials Group” (Journal of Critical Care 34 (2016) 95–102)

Hiran Bandeshe, Rob Boots, Joel Dulhunty, Rachael Dunlop, Anthony Holley, Paul Jarrett, Charles D. Gomersall, Jeff Lipman, Thomas Lo, Steven O'Donoghue, Jenny Paratz, David Paterson, Jason A. Roberts, Therese Starr, Di Stephens, Janine Stuart, Jane Thomas, Andrew Udy, Hayden White, The IPHIVAP investigators of the Australian and New Zealand Intensive Care Society Clinical Trials Group

Research output: Contribution to journalComment/debate

Abstract

The publisher regrets that the printed version of the above article contained a number of errors. The correct and final version follows. The publisher would like to apologize for any inconvenience caused.

Original languageEnglish
Pages (from-to)230
Number of pages1
JournalJournal of Critical Care
Volume35
DOIs
Publication statusPublished - Oct 2016
Externally publishedYes

Keywords

  • Nebulization
  • Unfractionated heparin
  • Ventilator associated complication
  • Ventilator associated pneumonia

Fingerprint Dive into the research topics of 'Erratum to “Is inhaled prophylactic heparin useful for prevention and management of pneumonia in ventilated ICU patients? The IPHIVAP investigators of the Australian and New Zealand Intensive Care Society Clinical Trials Group” (Journal of Critical Care 34 (2016) 95–102)'. Together they form a unique fingerprint.

Cite this